These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13107926)

  • 21. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Glycosuria observed during delta-cortisone treatment of hepatitis and cirrhosis].
    DUPUY R; VALLIN J; DESSERTENNES F; GIRAUD P
    Arch Mal Appar Dig Mal Nutr; 1957 Mar; 46(3):192-5. PubMed ID: 13425762
    [No Abstract]   [Full Text] [Related]  

  • 23. [The therapy of chronic hepatitis and liver cirrhoses with liver-mitochondrial suspensions].
    HOETZL HA
    Munch Med Wochenschr; 1960 Sep; 102():1670-4. PubMed ID: 13714958
    [No Abstract]   [Full Text] [Related]  

  • 24. [Early treatment of degenerative diseases of the liver parenchyma].
    DONHARDT A
    Dtsch Z Verdau Stoffwechselkr; 1953; 9():256-60. PubMed ID: 13150962
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical and biochemical observations on the use of large doses of testosterone propionate in acute and chronic liver disease.
    MORGAN FM; WHARTON GK; STARR P; COMMONS RR
    Am J Gastroenterol; 1954 Feb; 21(2):89-120. PubMed ID: 13124314
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous administration of liver extracts in hepatitis; preventive note.
    GIULINI R; PACE O
    Minerva Med; 1954 Sep; 45(77):733-7. PubMed ID: 13213762
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical study of the treatment of certain liver diseases with the potassium salt of orotic acid].
    DEMEULENAERE L
    Brux Med; 1961 Jul; 41():1045-54. PubMed ID: 13721751
    [No Abstract]   [Full Text] [Related]  

  • 29. The clinical usefulness of ACTH and cortisone in liver disease.
    SBOROV VM; BLUEMLE LW; NEEFE JR; GYORGY P
    Gastroenterology; 1955 May; 28(5):745-58. PubMed ID: 14380587
    [No Abstract]   [Full Text] [Related]  

  • 30. Neonatal hepatitis syndrome.
    Roberts EA
    Semin Neonatol; 2003 Oct; 8(5):357-74. PubMed ID: 15001124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric nonalcoholic fatty liver disease in 2009.
    Alisi A; Manco M; Vania A; Nobili V
    J Pediatr; 2009 Oct; 155(4):469-74. PubMed ID: 19772998
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapy of liver parenchymal diseases with total liver extracts].
    LASCH F
    Gastroenterologia; 1954 Nov; 82(5):270-84. PubMed ID: 13232153
    [No Abstract]   [Full Text] [Related]  

  • 33. Fulminant hepatitis requiring MARS and liver transplantation in a patient with Still's disease.
    Taccone FS; Lucidi V; Donckier V; Bourgeois N; Decaux G; Vandergheynst F
    Eur J Intern Med; 2008 Oct; 19(6):e26-8. PubMed ID: 18848162
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical studies on the therapeutic effect of the liver hydrolysate prohepar in the therapy of liver diseases under control of functional disorders in protein and bile pigment metabolism].
    GOHR H; GORGES T
    Z Gesamte Inn Med; 1953 Dec; 8(23):1073-7. PubMed ID: 13170184
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibitory effects of fermented brown rice and rice bran on the development of acute hepatitis in Long-Evans Cinnamon rats.
    Shibata T; Nagayasu H; Kitajo H; Arisue M; Yamashita T; Hatakeyama D; Iwasaki T; Kobayashi H
    Oncol Rep; 2006 Apr; 15(4):869-74. PubMed ID: 16525673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis.
    Samuhasaneeto S; Thong-Ngam D; Kulaputana O; Patumraj S; Klaikeaw N
    J Med Assoc Thai; 2007 Apr; 90(4):788-97. PubMed ID: 17487136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The favorable effect of the peridural block on the course of inflammatory liver diseases].
    HOTZL H; LAUDAHN G
    Munch Med Wochenschr; 1954 Dec; 96(51):1507-10. PubMed ID: 13235778
    [No Abstract]   [Full Text] [Related]  

  • 38. Cortisone and ACTH in hepatitis and cirrhosis.
    SVARTZ N
    Acta Med Scand Suppl; 1953; 287():39. PubMed ID: 13137964
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis.
    Anderson N; Borlak J
    Pharmacol Rev; 2008 Sep; 60(3):311-57. PubMed ID: 18922966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ACTH and cortisone in therapy of hepatitis and cirrhosis].
    GELIN G
    Bull Mem Soc Med Hop Paris; 1954 May 14-21; 70(15-16):533-7. PubMed ID: 13190394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.